Routine vitamin B12 screening may prevent irreversible nerve damage in type-2 diabetes

Date: November 20, 2018

Source: Society for Endocrinology

Summary:

Patients with type-2 diabetes, taking metformin, should have their vitamin B12 levels assessed more regularly to avoid irreversible nerve damage, according to a new study. The study findings suggest that earlier detection of vitamin B12 deficiency through routine screening of all metformin-treated, type-2 diabetes patients could reduce their risk of developing irreversible, painful and potentially disabling nerve damage.

See more at:

https://www.sciencedaily.com/releases/2018/11/181120211642.htm